I'm with Onionhead on this: what did our CEO - an engineering PhD with no apparent med school or bio research experience - what did he see in Leronlimab that all the other Big Pharma experts missed? How is that even possible, that a bio/medical neophyte stumbles across a potential miracle drug?
If you have any more details, LongTkt, please share them, I think the NP/Leronlimab story has the bones to build a Best Picture kind of movie.